Virulence attenuation of Candida albicans genetic variants isolated from a patient with a recurrent bloodstream infection

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Sampaio, Paula ^a   Santos, Marlene ^a   Correia, Alexandra ^a   Amaral, Fábio E ^b   Chavéz Galarza, Julio ^a,c   Costa de Oliveira, Sofia ^d   Castro, António G ^b   Pedrosa, Jorge ^b   Pais, Célia ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSIDAD NACIONAL DE TRUJILLO   (Peru)

^d University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOODSTREAM INFECTION; CANDIDA ALBICANS; CANDIDEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME RELEASE; EVOLUTIONARY ADAPTATION; FEMALE; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ISOLATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLAMMATION; KIDNEY NECROSIS; MACROPHAGE; MICROSATELLITE MARKER; MOUSE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; RECURRENT INFECTION; SPLEEN; STRESS; ANIMAL; CANDIDIASIS; FUNGEMIA; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; RECURRENT DISEASE; VIRULENCE;

CANDIDA ALBICANS; MUS;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; FUNGEMIA; GENETIC VARIATION; HUMANS; INFLAMMATION; INTERFERON-GAMMA; MICE; RECURRENCE; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE;

EID: 77956304308     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010155     Document Type: Article

References (64)

1. Pappas PG (2006) Invasive candidiasis. Infect Dis Clin North Am 20: 485-506.
2. Pelroth J, Choi B, Spellberg B (2007) Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Medical Mycology 45: 321-346.
3. Enoch DA, Ludlam HA, Brown NM (2006) Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol 55: 809-818.
4. Lockhart SR, Fritch JJ, Meier AS, Schroppel K, Srikantha T, et al. (1995) Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fingerprinting and C1 sequencing. J Clin Microbiol 33: 1501-9.
5. Shin JH, Park MR, Song JW, Shin DH, Jung SI, et al. (2004) Microevolution of Candida albicans strains during catheter-related candidemia. J Clin Microbiol 42: 4025-31.
6. Sampaio P, Gusmao L, Correia A, Alves C, Rodrigues AG, et al. (2005) New microsatellite multiplex PCR for Candida albicans strain typing reveals microevolutionary changes. J Clin Microbiol 43: 3869-3876.
7. Odds FC, Davidson AD, Jacobsen MD, Tavanti A, Whyte JA, et al. (2006) Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing. J Clin Microbiol 44: 3647-3658.
8. Jacobsen MD, Duncan AD, Bain J, Johnson EM, Naglik JR, et al. (2008) Mixed Candida albicans strain populations in colonized and infected mucosal tissues. FEMS Yeast Res 8: 1334-1338.
9. Forche A, Magee PT, Selmecki A, Berman J, May G (2009) Evolution in Candida albicans populations during a single passage through a mouse host. Genetics 182: 799-7811.
10. Diogo D, Bouchier C, d'Enfert C, Bougnoux ME (2009) Loss of heterozygosity in commensal isolates of the asexual diploid yeast Candida albicans. Fungal Genet Biol 46: 159-168.
11. Romani L (2000) Innate and adaptive immunity in Candida albicans infections and saprophytism. J Leukoc Biol 68: 175-179.
12. Huang W, Na L, Fidel PL, Schwarzenberger P (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190: 624-631.
13. Fradin C, De Groot P, MacCallum D, Schaller M, Klis F, et al. (2005) Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol Microbiol 56: 397-415.
14. Netea MG, Ferwerda G, van der Graaf CA, Van der Meer JW, Kullberg BJ (2006) Recognition of fungal pathogens by toll-like receptors. Curr Pharm Des 12: 4195-4201.
15. Richardson M, Rautemaa R (2009) How the host fights against Candida infections. Front Biosci 14: 4363-4375.
16. Djeu JY (1990) Role of tumor necrosis factor and colony-stimulating factors in phagocyte function against Candida albicans. Diagn Microbiol Infect Dis 13: 383-386.
17. Kullberg BJ, van 't Wout JW, Hoogstraten C, van Furth R (1993) Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis 168: 436-443.
18. Káposzta R, Tree P, Maródi L, Gordon S (1998) Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect Immun 66: 1708-1717.
19. Netea MG, van Tits LJ, Curfs JH, Amiot F, Meis JF, et al. (1999) Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J Immunol 163: 1498-1505.
20. Cenci E, Mencacci A, Spaccapelo R, Tonnetti R, Mosci P, et al. (1995) T helper cell type 1 (Th1) and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J Infect Dis 171: 1279-1288.
21. Lavigne LM, Schopf LR, Chung CL, Maylor R, Sypek JP (1998) The role of recombinant murine IL-12 and IFN-gamma in the pathogenesis of a murine systemic Candida albicans infection. J Immunol 160: 284-292.
22. Leigh JE, Steele C, Wormley FL, Jr., Luo W, et al. (1998) Th1/th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals - a pilot study in HIV-positive individuals with oropharyngeal candidiasis. J Acquir Immun Defic Syndr Human Retrovirol 19: 373-380.
23. Romani L (1999) Immunity to Candida albicans: Th1, th2 cells and beyond. Curr Opin Microbiol 2: 363-367.
24. Leigh JE, Steele C, Wormley FL Jr, Fidel PL Jr (2002) Salivary cytokine profiles in the immunocompetent individual with Candida-associated denture stomatitis. Oral Microbiol Immunol 17: 311-314.
25. Rozell B, Ljungdahl PO, Martínez P (2006) Host-pathogen interactions and the pathological consequences of acute systemic Candida albicans infections in mice. Curr Drug Targets 7: 483-494.
26. Pirofski LA, Casadevall A (2009) Rethinking T cell immunity in oropharyngeal candidiasis. J Exp Med 206: 269-273.
27. Biswas S, Van Dijck P, Datta A (2007) Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev 71: 348-376.
28. Mansour MK, Levitz SM (2002) Interactions of fungi with phagocytes. Curr Opin Microbiol 5: 359-365.
29. Lorenz MC, Fink GR (2002) Life and death in a macrophage: role of the glyoxylate cycle in virulence. Eukaryot Cell 1: 657-662.
30. Lorenz MC, Bender JA, Fink GR (2004) Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot Cell 3: 1076-87.
31. Calera JA, Zhao XJ, De Bernardis F, Sheridan M, Calderone R (1999) Avirulence of Candida albicans CaHK1 mutants in a murine model of hematogenously disseminated candidiasis. Infect Immun 67: 4280-4284.
32. Tavares D, Ferreira P, Arala-Chaves M (2003) Increased resistance in BALB/c mice to reinfection with Candida albicans is due to immunoneutralization of a virulence-associated immunomodulatory protein. Microbiology 149: 333-339.
33. MacCallum DM, Odds FC (2005) Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. Mycoses 48: 151-161.
34. Murciano C, Villamon E, Gozalbo D, Roig P, O'Connor JE, et al. (2006) Tolllike receptor 4 defective mice carrying point or null mutations do not show increased susceptibility to Candida albicans in a model of hematogenously disseminated infection. Med Mycol 44: 149-157.
35. Basu S, Hodgson G, Zhang HH, Katz M, Quilici C, et al. (2000) "Emergency" granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection. Blood 95: 3725-3733.
36. Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, et al. (2005) Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol 174: 4345-4355.
37. Bartie KL, Williams DW, Wilson MJ, Potts AJ, Lewis MA (2004) Differential invasion of Candida albicans isolates in an in vitro model of oral candidosis. Oral Microbiol Immunol 19: 293-296.
38. Tavanti A, Pardini G, Campa D, Davini P, Lupetti A, et al. (2004) Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes. J Clin Microbiol 42: 4726-34.
39. Hu Y, Farah CS, Ashman RB (2006) Isolates of Candida albicans that differ in virulence for mice elicit strain-specific antibody-mediated protective responses. Microbes Infect 8: 612-620.
40. Thewes S, Moran GP, Magee BB, Schaller M, Sullivan DJ, et al. (2008) Phenotypic screening, transcriptional profiling, and comparative genomic analysis of an invasive and non-invasive strain of Candida albicans. BMC Microbiol 8: 187-203.
41. MacCallum DM, Castillo L, Nather K, Munro CA, Brown AJ, et al. (2009) Property differences among the four major Candida albicans strain clades. Eukaryot Cell 8: 373-387.
42. Djeu JY, Blanchard DK, Halkias D, Friedman H (1986) Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol 137: 2980-2984.
43. Mencacci A, Cenci E, Del Sero G, Fè d'Ostiani C, Mosci P, et al. (1998) Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-alpha double-deficient mice infected with Candida albicans. Int Immunol 10: 37-48.
44. Romani L (2004) Immunity to fungal infections. Nat Rev Immunol 4: 1-23.
45. Schaller M, Boeld U, Oberbauer S, Hamm G, Hube B, Korting HC (2004) Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis. Microbiology 150: 2807-2813.
46. Mullaly SC, Kubes P (2007) Mast cell-expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis. Eur J Immunol 37: 224-234.
47. Zhang HH, Basu S, Wu F, Begley CG, Saris CJ, et al. (2007) Macrophagecolony stimulating factor is required for the production of neutrophil-promoting activity by mouse embryo fibroblasts deficient in G-CSF and GM-CSF. J Leukoc Biol 82: 915-925.
48. Romani L, Bistoni F, Puccetti P (2003) Adaptation of Candida albicans to the host environment: the role of morphogenesis in virulence and survival in mammalian hosts. Curr Opin Microbiol 6: 338-343.
49. Campos PR, Wahl LM (2009) The effects of population bottlenecks on clonal interference, and the adaptation effective population size. Evolution 63: 950-958.
50. Cheng S, Clancy CJ, Zhang Z, Hao B, Wang W, et al. (2007) Uncoupling of oxidative phosphorylation enables Candida albicans to resist killing by phagocytes and persist in tissue. Cell Microbiol 9: 492-501.
51. Bretagne S, Costa JM, Besmond C, Carsique RC, Calderone R (1997) Microsatellite polymorphism in the promoter sequence of the elongation factor 3 gene of Candida albicans as the basis for a typing system. J Clin Microbiol 35: 1777-1780.
52. Bougnoux ME, Tavanti A, Bouchier C, Gow NA, Magnier A, et al. (2003) Collaborative consensus for optimized multilocus sequence typing of Candida albicans. J Clin Microbiol 41: 5265-5266.
53. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
54. Bistoni F, Vecchiarelli A, Mazzolla R, Puccetti P, Marconi P, et al. (1985) Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans. Antimicrob Agents Chemother 27: 625-631.
55. Botelho AS, Teixeira L, Correia-da-Costa JM, Faustino AM, Castro AG, et al. (2007) Neospora caninum: high susceptibility to the parasite in C57BL/10ScCr mice. Exp Parasitol 115: 68-75.
56. Kretschmar M, Hube B, Bertsch T, Sanglard D, Merker R, et al. (1999) Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis. Infect Immun 67: 6637-6642.
57. Oliveira MS, Fraga AG, Torrado E, Castro AG, Pereira JP, et al. (2005) Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice. Infect Immun 73: 6299-6310.
58. Austyn JM, Gordon S (1981) F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 11: 805-815.
59. Lagasse E, Weissman IL (1996) Flow cytometric identification of murine neutrophils and monocytes. J Immunol Methods 197: 139-150.
60. Terrón MP, Paredes SD, Barriga C, Ortega E, Rodríguez AB (2004) Comparative study of the heterophil phagocytic function in young and old ring doves (Streptopelia risoria) and its relationship with melatonin levels. J Comp Physiol B 174: 421-427.
61. Ortega E, Marchena JM, García JJ, Barriga C, Rodríguez AB (2005) Norepinephrine as mediator in the stimulation of phagocytosis induced by moderate exercise. Eur J Appl Physiol 93: 714-718.
62. Shin YK, Kim KY, Paik YK (2005) Alterations of protein expression in macrophages in response to Candida albicans infection. Mol Cells 20: 271-279.
63. Monod M, Hube B, Hess D, Sanglard D (1998) Differential regulation of SAP8 and SAP9, which encode two new members of the secreted aspartic proteinase family in Candida albicans. Microbiology 144: 2731-2737.
64. Samaranayake LP, Raeside JM, MacFarlane TW (1984) Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 22: 201-207.